Researchers at Thomas Jefferson University are working hard to develop vaccines in an effort to fight some of the world’s toughest viruses and cancers. Back in 2017, Thomas Jefferson University was awarded a $30 million five-year contract over a five-year period to research safe vaccination solutions. Since then, university researchers have been developing strategies to find life changing answers to these global issues.
Read More
0 Comments Click here to read/write comments
Tags: Thomas Jefferson University, Vaccine Technology, virus research, brain cancer treatment, biotechnology events
A unique opportunity to advance research into the function of the human brain has been presented to three UCLA neuroscientists. Michele Basso, Dr. Peyman Golshani and Daniel Aharoni have received a $3.7 million, three-year grant from the National Institutes of Health (NIH) to develop imaging technology to record tens of thousands of neurons with the intent of learning how disease impacts the brain’s function.
Read More
0 Comments Click here to read/write comments
Tags: CA, UCLA School of Public Health, UCLA Funding statistics, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, UCLA research funding, nih research funding, university research funding, Neurological Research, Brain Disease, Healthcare Research, Mental Disorders, lab equipment suppliers, brain cancer treatment